Tune in to our hematology podcasts, where experts in the field of blood diseases unravel the complexities of hematology. Each episode covers the latest breakthroughs in the diagnosis, treatment, and management of hematologic conditions like leukemia, hemophilia, multiple myeloma and more. With in-depth discussions from leading hematologists, and insights from real-world cases, this podcast series provides healthcare professionals with the knowledge needed to navigate the world of blood disorders. Stay informed about cutting-edge research and hear inspiring stories of innovation in hematologic care.
Episode 51 - Podcast: What I'd Do Differently Tomorrow - Part 5 of RRMM Podcasts: Practical Insights for the First Relapse
Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand and clinical guidance evolves, healthcare professionals must navigate challenges related to risk stratification, treatment selection, sequencing strategies, and the integration of emerging immunotherapies into practice.
Clinicians may also face uncertainty in distinguishing mechanisms of action, managing immune-related toxicities, and selecting appropriate therapies in the context of treatment resistance. Additionally, real-world barriers such as staffing shortages, infusion capacity constraints, and workflow demands can complicate the implementation of optimal care. This podcast series features expert-led conversations that deliver practical insights and real-world strategies to support confident, guideline-informed decision-making in the management of RRMM.
Launch Date/Release: July 2, 2026
Expiration Date: August 31, 2027
FACULTY
Ajai Chari, MD
Professor of Clinical Medicine
University of California, San Francisco
Sagar Lonial, MD, FACP, FASCO
Chair and Professor
Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Chief Medical Officer
Winship Caner Institute | Emory University
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link (https://www.practicepointcme.com/CMEHome/rrmm-podcasts-practical-insights-for-the-first-relapse) prior to listening to this podcast.
2 Jul 2026
Episode 50 - Podcast: From Knowing to Doing: Overcoming Real-World Barriers - Part 4 of RRMM Podcasts: Practical Insights for the First Relapse
Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand and clinical guidance evolves, healthcare professionals must navigate challenges related to risk stratification, treatment selection, sequencing strategies, and the integration of emerging immunotherapies into practice.
Clinicians may also face uncertainty in distinguishing mechanisms of action, managing immune-related toxicities, and selecting appropriate therapies in the context of treatment resistance. Additionally, real-world barriers such as staffing shortages, infusion capacity constraints, and workflow demands can complicate the implementation of optimal care. This podcast series features expert-led conversations that deliver practical insights and real-world strategies to support confident, guideline-informed decision-making in the management of RRMM.
Launch Date/Release: July 2, 2026
Expiration Date: August 31, 2027
FACULTY
Ajai Chari, MD
Professor of Clinical Medicine
University of California, San Francisco
Sagar Lonial, MD, FACP, FASCO
Chair and Professor
Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Chief Medical Officer
Winship Caner Institute | Emory University
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link (https://www.practicepointcme.com/CMEHome/rrmm-podcasts-practical-insights-for-the-first-relapse) prior to listening to this podcast.
2 Jul 2026
Episode 49 - Podcast: Bispecific Antibodies Across Targets: Practical Integration in RRMM - Part 3 of RRMM Podcasts: Practical Insights for the First Relapse
Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand and clinical guidance evolves, healthcare professionals must navigate challenges related to risk stratification, treatment selection, sequencing strategies, and the integration of emerging immunotherapies into practice.
Clinicians may also face uncertainty in distinguishing mechanisms of action, managing immune-related toxicities, and selecting appropriate therapies in the context of treatment resistance. Additionally, real-world barriers such as staffing shortages, infusion capacity constraints, and workflow demands can complicate the implementation of optimal care. This podcast series features expert-led conversations that deliver practical insights and real-world strategies to support confident, guideline-informed decision-making in the management of RRMM.
Launch Date/Release: July 2, 2026
Expiration Date: August 31, 2027
FACULTY
Ajai Chari, MD
Professor of Clinical Medicine
University of California, San Francisco
Sagar Lonial, MD, FACP, FASCO
Chair and Professor
Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Chief Medical Officer
Winship Caner Institute | Emory University
This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link (https://www.practicepointcme.com/CMEHome/rrmm-podcasts-practical-insights-for-the-first-relapse) prior to listening to this podcast.
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
5.0 / 5
1 ratings
Spotify
5.0 / 5
2 ratings
Podcast Authority Score: 10 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
19
Social presence
0
YouTube
0
Engagement
0
Host of Practice Point CME - Hematology Podcast?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
